Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Mar 2023 for EXAGEN INC.. Read the official filing
Filing timeline
BuySaleMark Hazeltine
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark Hazeltine: trading record in brief
All filings by Mark Hazeltine on record concern Exagen Inc., in the capacity of chief executive. Over a trading history stretching from 17 May 2021 to 2 March 2023, the count stands at 6 filings.
Every open-market trade on record is a sale: 2 sales worth €15k. No amount is published for 1 filing, which the totals therefore leave out. Besides market trades, the filings include 3 share grants and 1 option exercise. So far in 2023, the count stands at no purchases and 2 sales.
The latest filing, published on 3 March 2023, reports an open-market sale in Exagen Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark Hazeltine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,667 shares0Common StockSEC:0001274737-23-000013:0
100,000 shares0Common StockSEC:0001274737-23-000011:0
5,821 shares@ US$2.692440.6% of flowCommon StockSEC:0001274737-23-000008:0
3,241 shares@ US$7.120.023% mcap96.1% of flowCommon StockSEC:0001274737-22-000018:0
63,500 shares0Common StockSEC:0001274737-22-000010:0
1,934 shares@ US$0.261.2% of flowCommon StockSEC:0001274737-21-000047:0
6 of 6 declarations
